Literature DB >> 9643346

Synthesis and accumulation of a receptor regulatory protein associated with lipid droplet accumulation in 3T3-L1 cells.

D J Orlicky1, J G Lieber, C L Morin, R M Evans.   

Abstract

Synthesis and accumulation of the recently identified prostaglandin F2alpha receptor regulatory protein (FPRP) was found to correlate closely with lipid droplet accumulation by 3T3-L1 preadipose cells. FPRP, a transmembrane glycoprotein, has been shown to regulate the binding of ligand to certain seven-transmembrane receptors. Anti-FPRP immunohistochemistry, Western blotting, and metabolic labeling/immunoprecipitation experiments demonstrated that FPRP was not detectable in undifferentiated 3T3-L1 cells. Interestingly, low levels of FPRP mRNA were detected in the undifferentiated 3T3-L1 cells. After induction of adipose differentiation, FPRP mRNA increased approximately 3 fold whereas FPRP synthesis increased approximately 50 fold. Differentiation induction with either dexamethasone/insulin/isobutylmethylxanthine or the thiazolidinedione derivative ADD 4743 were both effective at inducing FPRP accumulation and accumulation of lipid droplets. By co-immunohistochemical and lipid staining, greater than 99% of the cells accumulating lipid droplets possessed FPRP. FPRP mRNA and protein are also found in rat adipose tissue. Treatment of 3T3-L1 cells with an FPRP anti-sense oligonucleotide during differentiation decreased FPRP accumulation and resulted in a decrease in lipid droplets without altering the level of induction of a late marker of adipocyte differentiation, glycerol-3-phosphate dehydrogenase activity. Transient expression of an FPRP cDNA in undifferentiated 3T3-L1 cells was insufficient to induce lipid droplet accumulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9643346

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Loss of microRNA-7a2 induces hypogonadotropic hypogonadism and infertility.

Authors:  Kashan Ahmed; Mary P LaPierre; Emanuel Gasser; Rémy Denzler; Yinjie Yang; Thomas Rülicke; Jukka Kero; Mathieu Latreille; Markus Stoffel
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

2.  The tetraspanin D6.1A and its molecular partners on rat carcinoma cells.

Authors:  Christoph Claas; Joachim Wahl; David J Orlicky; Handan Karaduman; Martina Schnölzer; Tore Kempf; Margot Zöller
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

Review 3.  Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.

Authors:  Uchurappa Mala; Tapan Kumar Baral; Kumaravel Somasundaram
Journal:  BMC Cancer       Date:  2022-06-11       Impact factor: 4.638

4.  The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.

Authors:  Brittany Aguila; Adina Brett Morris; Raffaella Spina; Eli Bar; Julie Schraner; Robert Vinkler; Jason W Sohn; Scott M Welford
Journal:  Cancer Lett       Date:  2019-08-01       Impact factor: 8.679

5.  CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.

Authors:  W Guilmain; S Colin; E Legrand; J P Vannier; C Steverlynck; M Bongaerts; M Vasse; S Al-Mahmood
Journal:  Br J Cancer       Date:  2011-01-04       Impact factor: 7.640

6.  Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development.

Authors:  Jorge Marquez; Jianping Dong; Chun Dong; Changsheng Tian; Ginette Serrero
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.